Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday September 8, 2015:
Strategic Hotels & Resorts to be Acquired by Blackstone for $14.25/ShareThe Deal:
Strategic Hotels & Resorts, Inc.
BEE announced Tuesday, that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII L.P.
BX, under which Blackstone will acquire all outstanding shares of common stock of Strategic Hotels & Resorts, Inc., for $14.25 per share in cash, and all of the outstanding membership units of the Company's subsidiary, Strategic Hotels Funding L.L.C., not held by the Company, for $14.25 per unit in cash. The transaction value is approximately $6 billion.
The deal is expected to be completed by Q1 of 2016
Strategic Hotels & Resorts closed at $14.07 on Tuesday, a gain of 3.5%.
Microsoft Acquires AdallomThe Deal:
Microsoft's
MSFT Corporate Vice President, Cloud and Enterprise Marketing, Takeshi Numoto,
announced Tuesday, that Microsoft has acquired Adallom, an innovator in cloud security and a leader in helping customers protect their critical assets across cloud applications. Terms of the deal were not disclosed, but
Bloomberg reported the purchase price was $250 million
Microsoft closed at $43.89 Tuesday, up 3%.
Mylan to Launch Offer for Perrigo Directly to Perrigo Shareholders on Sept. 14Loading...
Loading...
:
Mylan N.V.
MYL announced Tuesday, its intent to commence a formal offer to exchange all outstanding ordinary shares of Perrigo Company plc
PRGO on September 14, 2015. Under the terms of the offer, Perrigo shareholders will receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share. Mylan shareholders have voted overwhelmingly in favor of the transaction.
Perrigo shares closed at $180.65 Tuesday, a gain of 1%.
Deal Reporter Says Big Pharma to Offer $300/Share for BlueBird BioThe Rumor:
Shares of BlueBird Bio
BLUE rose Tuesday, following a report from
Deal Reporter that big pharma could pay up to $300 per share for the Cambridge-based biotech company. That report was based on a
Life Sciences Report article dated September 2.
BlueBird did not respond to a request for comment.
BlueBird shares closed at $138.10 Tuesday, a gain of 6.79%.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in